Seeing Is Believing
VOR is currently covered by 6 analysts with an average price target of $27.04. This is a potential upside of $-0.72 (-2.59%) from yesterday's end of day stock price of $27.76.
Vor Biopharma's activity chart (see below) currently has 29 price targets and 44 ratings on display. The stock rating distribution of VOR is 62.5% BUY and 37.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 85% with an average time for these price targets to be met of 258.38 days.
Highest price target for VOR is $64, Lowest price target is $5, average price target is $20.75.
Most recent stock forecast was given by JACK ALLEN from BAIRD on 15-Oct-2025. First documented stock forecast 25-Mar-2021.
Currently out of the existing stock ratings of VOR, 10 are a BUY (62.5%), 6 are a HOLD (37.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$64
$35 (120.69%)
8 days ago
(15-Oct-2025)
4/5 (80%)
$33.78 (111.78%)
175
Buy
2 months 9 days ago
(14-Aug-2025)
6/6 (100%)
$-4.4 (-25.29%)
178
Hold
$11
3 months 27 days ago
(26-Jun-2025)
5/5 (100%)
$-23.2 (-67.84%)
387
Hold
$6
$-23 (-79.31%)
$6
5 months 14 days ago
(09-May-2025)
8/8 (100%)
$2.98 (98.68%)
342
Buy
$8
$-21 (-72.41%)
$10
7 months 2 days ago
(21-Mar-2025)
5/5 (100%)
$-9.4 (-54.02%)
334
What is VOR (Vor Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on VOR (Vor Biopharma) with a proven track record?
Which analyst has the current lower performing score on VOR (Vor Biopharma) with a proven track record?
Which analyst has the most public recommendations on VOR (Vor Biopharma)?
Which analyst is the currently most bullish on VOR (Vor Biopharma)?
Which analyst is the currently most reserved on VOR (Vor Biopharma)?